These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 4038580)
21. The use of aztreonam in pediatric patients: a review. Bosso JA; Black PG Pharmacotherapy; 1991; 11(1):20-5. PubMed ID: 1902290 [TBL] [Abstract][Full Text] [Related]
23. Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Brogden RN; Heel RC Drugs; 1986 Feb; 31(2):96-130. PubMed ID: 3512234 [TBL] [Abstract][Full Text] [Related]
24. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections. Bjornson HS; Ramirez-Ronda C; Saavedra S; Rivera-Vázquez CR; Liu C; Hinthorn DR Clin Ther; 1993; 15(1):65-78. PubMed ID: 8458056 [TBL] [Abstract][Full Text] [Related]
25. Tobramycin sulfate: a summary of worldwide experience from clinical trials. Bendush CL; Weber R J Infect Dis; 1976 Aug; 134 Suppl():S219-34. PubMed ID: 787450 [TBL] [Abstract][Full Text] [Related]
26. Aztreonam in the treatment of aerobic, gram-negative bacillary infections in pediatric patients. Trujillo H; Harry N; Arango A; Benítez G; Restrepo F; Mejía GI; Castrillón AL Chemotherapy; 1989; 35 Suppl 1():25-30. PubMed ID: 2731447 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of aztreonam versus tobramycin for aerobic gram-negative bacilli lower respiratory tract infections. Rodriguez JR; Ramirez-Ronda CH Am J Med; 1985 Feb; 78(2A):42-3. PubMed ID: 4038578 [TBL] [Abstract][Full Text] [Related]
28. Successful response of severe neonatal gram-negative infection to treatment with aztreonam. Constantopoulos A; Thomaidou L; Loupa H; Papoulias G Chemotherapy; 1989; 35 Suppl 1():101-5. PubMed ID: 2731446 [TBL] [Abstract][Full Text] [Related]
29. Clinical experience with aztreonam in four Mediterranean countries. Daikos GK Rev Infect Dis; 1985; 7 Suppl 4():S831-5. PubMed ID: 2934787 [TBL] [Abstract][Full Text] [Related]
30. [The role of carbapenems in the treatment of nosocomial infection]. Martínez Lacasa J; Garau J Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():78-85. PubMed ID: 9410075 [TBL] [Abstract][Full Text] [Related]
31. Aztreonam in the treatment of bone and joint infections caused by gram-negative bacilli. Simons WJ; Lee TJ Rev Infect Dis; 1985; 7 Suppl 4():S783-8. PubMed ID: 2934786 [TBL] [Abstract][Full Text] [Related]
32. Do we need the third-generation cephalosporins? Neu HC J Antimicrob Chemother; 1984 Sep; 14 Suppl B():1-12. PubMed ID: 6501133 [TBL] [Abstract][Full Text] [Related]
33. Aztreonam therapy for serious gram-negative infections in children. Stutman HR; Chartrand SA; Tolentino T; Friedhoff L; Marks MI Am J Dis Child; 1986 Nov; 140(11):1147-51. PubMed ID: 3766490 [TBL] [Abstract][Full Text] [Related]
34. Aztreonam in the prevention and treatment of infection in neutropenic cancer patients. Rolston KV; Bodey GP; Elting L Am J Med; 1990 Mar; 88(3C):24S-29S; discussion 38S-42S. PubMed ID: 2180294 [TBL] [Abstract][Full Text] [Related]